Unique Polypharmacology Nuclear Receptor Modulator Blocks Inflammatory Signaling Pathways-Reference-Cited by-同舟云学术

Unique Polypharmacology Nuclear Receptor Modulator Blocks Inflammatory Signaling Pathways

Published:2019-04-05 Issue:5 Volume:14 Page:1051-1062
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Chang Mi Ra¹,Ciesla Anthony¹,Strutzenberg Timothy S.¹,Novick Scott J.¹,He Yuanjun¹,Garcia-Ordonez Ruben D.¹,Frkic Rebecca L.²,Bruning John B.²^ORCID,Kamenecka Theodore M.¹^ORCID,Griffin Patrick R.¹³^ORCID

Affiliation:

1. Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, United States

2. Institute for Photonics & Advanced Sensing (IPAS), School of Biological Sciences, University of Adelaide, Adelaide, South Australia 5005, Australia

3. Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, Florida 33458, United States

Funder

Center for Scientific Review

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.9b00236

Reference45 articles.

1. The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs

2. Glucocorticoid Receptor Transcriptional Activity Determined by Spacing of Receptor and Nonreceptor DNA Sites